Recent advancements in AI and telemedicine are propelling digital health growth in Asia-Pacific and Western markets, with significant funding and…
Cloud Computing in Healthcare: Accelerating Digital Transformation Across Global Regions
This analysis explores cloud computing adoption in healthcare, comparing North America, Europe, and Asia-Pacific. It highlights post-COVID telemedicine growth, data…
What UK’s clinician-led AI regulation means for global medtech competitiveness
UK medical bodies advocate for evidence-based AI regulation to enhance patient safety and workforce training, contrasting with EU and US…
Mass General Brigham’s AI model validation reveals 30% improvement in early dementia diagnosis
Mass General Brigham’s AI model uses self-supervised learning on brain MRI scans to predict dementia risk with over 90% accuracy,…
10% eGFR improvement in diabetic kidney disease highlights senolytic therapy potential
Senolytic therapies, such as dasatinib plus quercetin, show promise in diabetic kidney disease by targeting cellular senescence. Clinical trials report…
NICE’s 2023 guidance reveals digital CBT reduces bulimia symptoms by 50%
NICE conditionally recommends ‘Overcoming Bulimia Online’, a digital CBT programme, after clinical trials show 50% reduction in binge eating episodes.…
AI diagnostic accuracy of 85% reveals shift in patient-clinician dynamics
Generative AI tools like ChatGPT are altering healthcare by enhancing patient information-seeking and clinical support. Studies show 85% diagnostic accuracy,…
Eolas Medical secures $12M Series A for AI clinical decision platform
Eolas Medical’s $12 million Series A funding aims to scale its AI-powered knowledge platform across over 400 NHS clinical sites,…
Sanome’s MEMORI AI study reveals 3-day early infection prediction in NHS hospitals
Sanome’s MEMORI AI tool, implemented at The Royal Hospital for Neuro-disability and East Kent Hospitals, uses machine learning to detect…
Phase 1 trial of RTR242 reveals enhanced lysosomal function for Alzheimer’s potential
Longevity Technology reports the Phase 1 safety trial of autophagy promoter RTR242 shows no serious adverse events, with preliminary data…
How AI agents in home care reduce hospital readmissions by 18%
An analysis of AI deployment in home care, highlighting clinical benefits like 18% fewer readmissions, regulatory differences between U.S. and…
What White House AI executive orders mean for patient safety in underserved regions
Analysis of federal AI oversight blocking state laws, based on StatNews reports, showing how regulatory fragmentation delays health tech adoption,…